Long-term outcomes with mechanical and tissue valves

Journal of Heart Valve Disease

Volumn 11, Issue SUPPL. 1, 2002, Pages

  Khan, Steven ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANIMAL TISSUE; AORTA VALVE PROSTHESIS; ARTICLE; BLEEDING; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAFT FAILURE; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL SOCIETY; MITRAL VALVE PROSTHESIS; NONHUMAN; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL; THROMBOEMBOLISM; UNITED STATES; VALVULAR HEART DISEASE;

HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; REOPERATION; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTORS;

EID: 0036216951     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial
2. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses
3. Twenty-year comparison of tissue and mechanical valve replacement
4. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
5. Long-term results of valve replacement with the St. Jude Medical valve
6. Twelve years' experience with the St. Jude Medical valve prosthesis
7. The St. Jude Medical prosthesis. A thirteen-year experience
8. Excellent long-term results of cardiac valve replacement with the St Jude Medical valve prosthesis
9. Age, coronary disease, and thromboembolism risk after St. Jude mechanical valve replacement
10. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy
11. Reoperation on prosthetic heart values. Patient-specific estimates of in-hospital events
12. Twenty-year clinical experience with porcine bioprostheses
13. ACC/AHA guidelines for the management of Patients with Valvular Heart Disease